Feasibility Study to Byproduce Medical Radioisotopes in a Fusion Reactor

Author:

Li Jia1,Zheng Shanliang2

Affiliation:

1. School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230000, China

2. Institute of Plasma Physics, Chinese Academy of Sciences, Hefei 230000, China

Abstract

Currently, international nuclear fission reactors producing medical isotopes face the problem of shutdown and maintenance, decommissioning, or dismantling, while the production capacity of domestic research reactors for medical radioisotopes is inadequate, and the supply capacity for medical radioisotopes faces major challenges in the future. Fusion reactors are characterized by high neutron energy, high flux density, and the absence of highly radioactive fission fragments. Additionally, compared to fission reactors, the reactivity of the fusion reactor core is not significantly affected by the target material. By building a preliminary model of the China Fusion Engineering Test Reactor (CFETR), a Monte Carlo simulation was performed for particle transport between different target materials at a fusion power of 2 GW. The yields (specific activity) of six medical radioisotopes (14C, 89Sr, 32P, 64Cu, 67Cu, and 99Mo) with various irradiation positions, different target materials, and different irradiation times were studied, and compared with those of other high-flux engineering test reactors (HFETR) and the China Experimental Fast Reactor (CEFR). The results show that this approach not only provides competitive medical isotope yield, but also contributes to the performance of the fusion reactor itself, e.g., tritium self-sustainability and shielding performance.

Funder

National Natural Science Foundation of China

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Reference27 articles.

1. Cherry, S.R., Sorenson, J.A., and Phelps, M.E. (2012). Physics in Nuclear Medicine E-Book, Elsevier Health Sciences.

2. (2022, July 05). Medium and Long-Term Development Plan for Medical Isotopes (2021–2035). Available online: https://www.ccnta.cn/article/6220.html.

3. Current status and future perspective of radiopharmaceuticals in China;Hu;Eur. J. Nucl. Med. Mol. Imaging,2022

4. Production Status and Technical Prospects of Medical Radioisotope 99 Mo/99 m Tc;Ziwei;Nucl. Phys. Rev.,2019

5. Isotope technologies in INPC: State of the art and perspective;J. Isot.,2011

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3